Inactive Instrument
CUSPIS CAP L Stock Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 313M 218M 190M 176M 162M 308M 20.77B 2.1B 824M 10.23B 818M 800M 35.18B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 313M 218M 190M 176M 162M 308M 20.77B 2.1B 824M 10.23B 818M 800M 35.18B | EV / Sales 2026 * |
112x | EV / Sales 2027 * | 4.29x |
| Free-Float |
86.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 2016-08-09 |
Joshua George
DFI | Director of Finance/CFO | - | 2024-04-07 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 2026-04-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 2016-08-09 |
Robert Galyen
BRD | Director/Board Member | - | 2023-06-30 |
Jack Perkowski
CHM | Chairman | 76 | 2023-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 217M | ||
| +4.37% | -6.19% | +148.10% | +36.76% | 6.3B | ||
| +1.31% | -1.59% | -29.65% | -47.22% | 2.31B | ||
| -7.19% | -0.44% | +122.70% | +193.71% | 1.17B | ||
| -2.91% | -14.98% | +49.07% | +141.06% | 1.16B | ||
| +1.17% | -5.52% | +18.81% | +1.66% | 565M | ||
| +0.66% | +4.84% | -23.16% | -53.38% | 535M | ||
| +2.12% | -5.10% | -18.96% | -9.91% | 281M | ||
| +2.39% | -6.55% | -46.60% | +10.05% | 230M | ||
| -1.99% | -9.20% | -36.48% | -55.42% | 193M | ||
| Average | +1.39% | -4.29% | +20.43% | +24.14% | 1.42B | |
| Weighted average by Cap. | +1.82% | -2.61% | +81.62% | +37.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.95M 1.7M 1.57M 1.45M 2.75M 186M 18.77M 7.37M 91.5M 7.31M 7.15M 315M | 73M 50.78M 44.41M 40.97M 37.84M 71.79M 4.84B 489M 192M 2.39B 191M 186M 8.2B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















